In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...
Used the gel for dry eyelids. Twice a day for the first few days, now once a day. Completely cleared up with a couple of ...
After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...
The US Food and Drug Administration (FDA) has issued a Complete Response Letter to Aldeyra Therapeutics for its New Drug Application of reproxalap for the treatment of dry eye dis ...
Beware! PHMB in your eye drops could be secretly harming your ocular surface. PHMB is a powerful antimicrobial preservative ...
It’s like a drink of water for my under-eyes.
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced ...
India Today on MSN
Long hours on screens? Women may face higher risk of digital eye strain
Spending long hours on phones, laptops, and tablets can strain the eyes. Experts say women may experience stronger symptoms ...
Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update. The company received an FDA Complete Response Letter (CRL) regarding its New ...
India faces a shortage of eye specialists as vision problems rise. An expert explains how strengthening optometry and ...
Discover how menopause affects eye health, from dry eyes to vision changes, and the importance of regular eye evaluations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results